Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: DP-Enalapril
Active Ingredient: Enalapril maleate 5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Cadila Pharmaceuticals Limited, Gujarat State, India
Product: DP-Enalapril
Active Ingredient: Enalapril maleate 10mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Cadila Pharmaceuticals Limited, Gujarat State, India
Product: DP-Enalapril
Active Ingredient: Enalapril maleate 20mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Cadila Pharmaceuticals Limited, Gujarat State, India
Product: Mupider
Active Ingredient: Mupirocin 20mg/g
Dosage Form: Topical ointment
New Zealand Sponsor: ABM Pharma Limited
Manufacturer: Kleva SA, Athens, Greece
Product: Reclens Eye Wash
Active Ingredients: Monobasic potassium phosphate 6.8mg/mL
Sodium chloride 5.7mg/mL
Dosage Form: Eye irrigation
New Zealand Sponsor: Tollot Pty Limited t/a Aaxis Pacific
Manufacturer: Opto-Pharm Pte Limited, Singapore
Product: Spren 100
Active Ingredient: Aspirin 100mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (New Zealand) Limited t/a Healthcare Logistics
Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia
Dated this 29th day of August 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).